查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417203

酒糟治療市場報告：2030 年趨勢、預測和競爭分析

Rosacea Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

酒糟的治療趨勢和預測

至2030年，全球酒糟治療市場預計將達到31.6億美元，2024年至2030年的年複合成長率為7.8%。該市場的主要促進因素是酒糟發病率和患病率的上升、聯合治療、組合產品的成長趨勢以及老年人口數量的增加。全球酒糟治療市場的未來看起來充滿希望，抗生素、α促效劑、類視色素類固醇、免疫抑制劑和抗高血壓藥物市場充滿機會。

酒糟治療市場洞察

Lucintel 預計 Topics 在預測期內將實現最高成長。

由於消費者知識的擴大、新藥的開發以及準確診斷的技術發展，預計北美地區在預測期內將出現最高的成長。

常問問題

Q.1酒糟治療的市場規模有多大？

A1. 到 2030 年，全球酒糟治療市場預計將達到 31.6 億美元。

Q.2酒糟治療市場的成長預測為何：

A2. 2024年至2030年，全球酒糟治療市場預計將以7.8%的年複合成長率成長。

Q.3 影響酒糟治療市場成長的關鍵因素有哪些：

A3. 該市場的主要驅動力是酒糟發病率和聯合治療的上升、組合產品的成長趨勢以及老年人口數量的增加。

Q4.市場的主要細分市場是：

A4.酒糟治療市場的未來看起來充滿希望，抗生素、α促效劑、類視色素A、皮質類固醇、免疫抑制劑和抗高血壓藥物市場都有機會。

Q5.市場的主要企業是：

A5. 主要的酒糟治療公司如下。

  • Galderma
  • Allergan
  • Bayer
  • Bausch Health Companie
  • Leo Pharma
  • Sol-Gel Technologies
  • Foamix Pharmaceuticals
  • Aclaris Therapeutics
  • Anaptysbio

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計 Topics 在預測期內將出現最高成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於消費者知識的擴展、新藥的開發以及準確診斷的技術發展，預計北美在預測期內將經歷最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球酒糟治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球酒糟治療市場趨勢（2018-2023）和預測（2024-2030）
  • 按藥物類別分類的全球酒糟治療市場
    • 抗生素
    • α促效劑
    • 類視色素A
    • 皮質類固醇
    • 免疫抑制劑
    • 抗高血壓
    • 其他
  • 按管理方法分類的全球酒糟治療市場
    • 外用
    • 口服

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球酒糟治療市場（按地區）
  • 北美酒糟治療市場
  • 歐洲酒糟治療市場
  • 亞太地區酒糟治療市場
  • 其他地區酒糟治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按藥物類別分類的全球酒糟治療市場成長機會
    • 按管理方法分類的全球酒糟治療市場成長機會
    • 按地區分類的全球酒糟治療市場成長機會
  • 全球酒糟治療市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球酒糟治療市場的產能
    • 全球酒糟治療市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Galderma
  • Allergan
  • Bayer
  • Bausch Health Companie
  • Leo Pharma
  • Sol-Gel Technologies
  • Foamix Pharmaceuticals
  • Aclaris Therapeutics
  • AnaptysBio
簡介目錄

Rosacea Treatment Trends and Forecast

The future of the global rosacea treatment market looks promising with opportunities in the antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents markets. The global rosacea treatment market is expected to reach an estimated $3.16 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are rising rosacea incidence and prevalence combination therapies, growing the tendency for combination products, and growing number of elderly people.

A more than 150-page report is developed to help in your business decisions.

Rosacea Treatment by Segment

The study includes a forecast for the global rosacea treatment by drug class, mode of administration and region.

Rosacea Treatment Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antibiotics
  • Alpha agonists
  • Retinoids
  • Corticosteroids
  • Immunosuppressants
  • Antihypertensive Agents
  • Others

Rosacea Treatment Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Topical
  • Oral

Rosacea Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Rosacea Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rosacea treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rosacea treatment companies profiled in this report include-

  • Galderma
  • Allergan
  • Bayer
  • Bausch Health Companie
  • Leo Pharma
  • Sol-Gel Technologies
  • Foamix Pharmaceuticals
  • Aclaris Therapeutics
  • Anaptysbio

Galderma, Allergan, Bayer, Bausch Health Companies, Leo Pharma, Sol-Gel Technologies, Foamix Pharmaceuticals, Aclaris Therapeutics, and AnaptysBio are the major suppliers in the rosacea treatment market.

Rosacea Treatment Market Insights

Lucintel forecasts that topical is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to expanding consumer knowledge, the creation of new medications, and technical developments for precise diagnosis.

Features of the Global Rosacea Treatment Market

Market Size Estimates: Rosacea treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rosacea treatment market size by drug class, mode of administration, and region in terms of value ($B).

Regional Analysis: Rosacea treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug class, mode of administration, and regions for the rosacea treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rosacea treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rosacea treatment market size?

Answer: The global rosacea treatment market is expected to reach an estimated $3.16 billion by 2030.

Q.2 What is the growth forecast for rosacea treatment market?

Answer: The global rosacea treatment market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rosacea treatment market?

Answer: The major drivers for this market are rising rosacea incidence and prevalence combination therapies, growing the tendency for combination products, and growing number of elderly people.

Q4. What are the major segments for rosacea treatment market?

Answer: The future of the rosacea treatment market looks promising with opportunities in the antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents markets.

Q5. Who are the key Rosacea Treatment Market companies?

Answer: Some of the key rosacea treatment companies are as follows.

  • Galderma
  • Allergan
  • Bayer
  • Bausch Health Companie
  • Leo Pharma
  • Sol-Gel Technologies
  • Foamix Pharmaceuticals
  • Aclaris Therapeutics
  • Anaptysbio

Q6. Which rosacea treatment market segment will be the largest in future?

Answer: Lucintel forecasts that topical is expected to witness highest growth over the forecast period.

Q7. In rosacea treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to expanding consumer knowledge, the creation of new medications, and technical developments for precise diagnosis.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the rosacea treatment market by drug class (antibiotics, alpha agonists, retinoids,corticosteroids, immunosuppressants, antihypertensive agents, and others), mode of administration (topical and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rosacea Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Rosacea Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Rosacea Treatment Market by Drug Class
    • 3.3.1: Antibiotics
    • 3.3.2: Alpha agonists
    • 3.3.3: Retinoids
    • 3.3.4: Corticosteroids
    • 3.3.5: Immunosuppressants
    • 3.3.6: Antihypertensive Agents
    • 3.3.7: Others
  • 3.4: Global Rosacea Treatment Market by Mode of Administration
    • 3.4.1: Topical
    • 3.4.2: Oral

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Rosacea Treatment Market by Region
  • 4.2: North American Rosacea Treatment Market
    • 4.2.2: North American Rosacea Treatment Market by Mode of Administration: Topical and Oral
  • 4.3: European Rosacea Treatment Market
    • 4.3.1: European Rosacea Treatment Market by Drug Class : Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others
    • 4.3.2: European Rosacea Treatment Market by Mode of Administration: Topical and Oral
  • 4.4: APAC Rosacea Treatment Market
    • 4.4.1: APAC Rosacea Treatment Market by Drug Class : Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others
    • 4.4.2: APAC Rosacea Treatment Market by Mode of Administration: Topical and Oral
  • 4.5: ROW Rosacea Treatment Market
    • 4.5.1: ROW Rosacea Treatment Market by Drug Class: Antibiotics, Alpha agonists, Retinoids,Corticosteroids,Immunosuppressants,Antihypertensive Agents, and Others
    • 4.5.2: ROW Rosacea Treatment Market by Mode of Administration: Topical and Oral

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Rosacea Treatment Market by Drug Class
    • 6.1.2: Growth Opportunities for the Global Rosacea Treatment Market by Mode of Administration
    • 6.1.3: Growth Opportunities for the Global Rosacea Treatment Market by Region
  • 6.2: Emerging Trends in the Global Rosacea Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Rosacea Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rosacea Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Galderma
  • 7.2: Allergan
  • 7.3: Bayer
  • 7.4: Bausch Health Companie
  • 7.5: Leo Pharma
  • 7.6: Sol-Gel Technologies
  • 7.7: Foamix Pharmaceuticals
  • 7.8: Aclaris Therapeutics
  • 7.9: AnaptysBio